Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary
Compounding Law; Health Care; Awareness of all Types of Compounding Issues;
Pharmacy Benefit Managers (PBMs), Outsourcing Facilities
Food and Drug Administration and Compliance Issues
Wednesday, February 22, 2017
Question of the day February 22, 2017 Did President Trump severely limit compounding pharmacists' ability to compound many prescriptions with his executive order limiting regulations? Why or why not? Will the FDA be required under the executive order to scrap all non-statutory required regulations and guidance, leaving the compounding industry in the dark and very limited on what is permissible under federal law? Why or why not? Will we see more enforcement and more criminal and civil actions for violations under the DSQA than in the past?